Abigail Beaney, Author at Clinical Trials Arena

Bavarian Nordic’s mpox vaccine to be trialled in pregnant women and infants

Abigail Beaney — Thu, 07 Nov 2024 11:53:18 +0000

Pregnant women and infants are at risk should they contract mpox but there are no approved vaccines for this population.

Abigail Beaney — Wed, 06 Nov 2024 11:38:19 +0000

Trump has not been vocal about healthcare policies but indicated that RFK Jr. will have a big influence on the sector.

Abigail Beaney — Tue, 05 Nov 2024 14:03:22 +0000

Viking Therapeutics has announced its oral formulation of VK2735 has scored in a Phase I trial at ObesityWeek 2024.

Abigail Beaney — Mon, 04 Nov 2024 12:12:33 +0000

Endeveca Bio discovered 710GO’s potential as a drug for weight loss while developing a cachexia preventative.

Abigail Beaney — Wed, 30 Oct 2024 12:55:30 +0000

Lilly’s Alzheimer’s drug Kisunla was approved in the US, Japan, and the UK, among other countries.

Abigail Beaney — Tue, 29 Oct 2024 12:19:23 +0000

After both receiving FDA approval in UC, J&J and Eli Lilly are racing for their IL-23 inhibitors to get the green light in Crohn’s disease.

Abigail Beaney — Fri, 18 Oct 2024 09:33:24 +0000

With less than three weeks until Americans cast their vote, what would healthcare look under a Harris or Trump administration?

Abigail Beaney — Tue, 15 Oct 2024 08:12:44 +0000

During Covid-19, US companies had to find onshore manufacturing. Experts believe this may also be an answer to the BIOSECURE Act.

Abigail Beaney — Wed, 09 Oct 2024 10:51:03 +0000

Speaking to the Clinical Trials Arena, experts share their thoughts on the next steps for Cassava Sciences.

Abigail Beaney — Tue, 08 Oct 2024 09:43:48 +0000

Scholar Rock’s stock price increased by 362% after the company announced data from the Phase III SAPPHIRE trial of apitegromab,